Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Feeling hot, Injection site pain
Clinical narrative: patient experienced soreness at the injection site; About 3-4 days later, the injected arm (Left) became red; Arm hotness; The patient feels that she did not get the full dose of the vaccine; The patient feels that the pharmacist who was injecting the vaccine, pulled the needle out too soon; perhaps the pharmacist went under the skin and not into the muscle; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of fatigue (1st dose received on an unknown date, for tolerance of1 st dose of Shingrix, refer case US2024152154).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: patient experienced soreness at the injection site), erythema of extremities (Verbatim: About 3-4 days later, the injected arm (Left) became red), extremities hot feeling of (Verbatim: Arm hotness), underdose (Verbatim: The patient feels that she did not get the full dose of the vaccine), wrong technique in product usage process (Verbatim: The patient feels that the pharmacist who was injecting the vaccine, pulled the needle out too soon) and product administered at inappropriate site (Verbatim: perhaps the pharmacist went under the skin and not into the muscle). The outcome of the injection site pain, erythema of extremities, extremities hot feeling of, underdose, wrong technique in product usage process and product administered at inappropriate site were unknown.   It was unknown if the reporter considered the injection site pain, erythema of extremities and extremities hot feeling of to be related to Shingrix.     It was unknown if the company considered the injection site pain, erythema of extremities and extremities hot feeling of to be related to Shingrix.   Linked case(s) involving the same patient:US2024152154   Additional Information: GSK Receipt Date: 03-DEC-2024 The reporter is a friend of the patient. The reporter did not wish to provide date of birth, or the initials of the patient.  The reporter stated that the patient received both doses of Shingrix, the second dose being with in the recommended time frame of the first (2-6 months).  After the second dose, the patient experienced soreness at the injection site. About 3-4 days later, the injected arm (Left) became red, and the redness proceeded down the whole left arm.  The arm is red and hot.  The patient felt that she did not get the full dose of the vaccine (AE - Underdose), because she did not feel the medication going in (like she did with the first dose).  The patient felt that the pharmacist who was injecting the vaccine, pulled the needle out too soon and perhaps the pharmacist went under the skin and not into the muscle, which led to underdose, wrong technique in product usage process and product administered at inappropriate site.; Sender's Comments:  US-GSK-US2024152154:Original Case : US2024152154